Category: Cancer Treatment
Global Cancer Treatment
-
Digital X-ray Market by Portability (Fixed, Portable), Applications (Orthopedic, Dental, Diagnostic, Cancer, Pediatric), Technology (Direct, Computed), System (Retrofit, New), End Users, Price Range, Type, and Region - Global Forecast to 2029
... market is projected to reach USD 6.6 billion by 2029 from USD 5.4 billion in 2024, at a CAGR of 4.0% from 2024 to 2029. The rising prevalence of chronic diseases, coupled with increasing demand ... Read More
-
Liquid Biopsy Market by Product & Service (Kits, Instruments), Circulating Biomarker (CTC, ctDNA, cfDNA), Technology (NGS, PCR), Application (Cancer (Lung, Breast, Prostate), Non-cancer (NIPT, Infectious)), Sample Type (Blood) - Global Forecast to 2029
... biopsy market is valued at an estimated USD 6.4 billion in 2024 and is projected to reach USD 11.3 billion by 2029 at a CAGR of 11.9% during the forecast period. Liquid biopsy presents numerous ... Read More
-
Global Cancer Biomarkers Market Report and Forecast 2024-2032
... grow at a CAGR of 14.30% and is likely to reach USD 52.4 billion by 2032. It is driven by growing emphasis on early detection and personalized medicine across the globe. Global Cancer Biomarkers Market ... Read More
-
Global Colonoscopy Devices Market Report by Products (Colonoscope, Visualization system, and Others), Application (Colorectal Cancer, Ulcerative Colitis, Crohns Disease, and Others), End-User (Hospitals, Clinics & Ambulatory surgical centers, and Others), Region and Company Analysis 2024-2032
... Market for colonoscopy devices is anticipated to have grown to about US$ 2.84 billion by 2032 from US$ 1.81 billion in 2023, with a compound annual growth rate of 5.13% between 2024 and 2032. A ... Read More
-
Colorectal Cancer Screening Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... has been Compound Annual growth Rate of 4.1%.The valuation of Colorectal Cancer Screening Market Size was USD 17.05 billion in 2023 and is expected to increase from USD 17.83 Billion in 2024 to USD 24.65 ... Read More
-
2024 Global Forecast for Pd-1 And Pd-L1 Inhibitors Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx ... Read More
-
2024 Global Forecast for Pet Cancer Therapeutics Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
2024 Global Forecast for Patient Derived Xenograft (Pdx) Models Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... 50 countries. The product or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase ... Read More
-
2024 Global Forecast for Breast Cancer Liquid Biopsy Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... countries. The product or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from ... Read More
-
2024 Global Forecast for Pancreatic Cancer Therapeutics And Diagnostics Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... 50 countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD ... Read More
-
2024 Global Forecast for Cancer Gene Therapy Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
2024 Global Forecast for Cancer Immunotherapy Drug Discovery Outsourcing Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... 50 countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD ... Read More
-
2024 Global Forecast for Brachytherapy Treatment Planning Systems Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... countries. The product or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from ... Read More
-
Cancer Biomarkers Market by Profiling Technology (Omics, Imaging), Cancer (Lung, Breast, Leukemia, Melanoma, Colorectal), Product (Instruments, Consumables), Application (Diagnostics, R&D, Prognostics), Enduser, and Region - Global Forecast to 2029
... projected to reach USD 42.0 billion by 2029 from USD 24.5 billion in 2024, at a CAGR of 11.3% during the forecast period. Factors like the rapid improvements in technology propel market expansion. in the ... Read More
-
Global Multiple Myeloma Therapeutics Databank Market Report
... 2021 to 2029. Medication segment is expected to be the highest contributor to this market, with $8,265.9 Million in 2020, and is anticipated to reach $14,610.5 Million by 2029, registering a CAGR of 6.57%. Medication ... Read More
-
Global Cancer Supportive Care Drugs Databank Market Report
... 6.77% from 2021 to 2029. Bisphosphonates segment is expected to be the highest contributor to this market, with $3,463.6 Million in 2020, and is anticipated to reach $6,456.7 Million by 2029, registering a CAGR of ... Read More
-
Global Stomach Cancer Treatment Databank Market Report
... 2023 to 2031. Targeted Therapy segment is expected to be the highest contributor to this market, with $2,319.0 Million in 2022, and is anticipated to reach $5,613.5 Million by 2031, registering a CAGR of 10.38%. ... Read More
-
Global Next Generation Cancer Diagnostics Databank Market Report
... 8.47% from 2023 to 2031. Next-Generation Sequencing segment is expected to be the highest contributor to this market, with $4,346.5 Million in 2022, and is anticipated to reach $9,095.4 Million by 2031, registering a CAGR ... Read More
-
Global Anti-Cancer Drug Databank Market Report
... 2031. Targeted Therapy segment is expected to be the highest contributor to this market, with $43,423.4 Million in 2022, and is anticipated to reach $75,119.7 Million by 2031, registering a CAGR of 6.32%. Hormonal Therapy ... Read More
-
Global Cancer Diagnostics Databank Market Report
... 2031. Consumables segment is expected to be the highest contributor to this market, with $167,321.8 Million in 2022, and is anticipated to reach $261,623.1 Million by 2031, registering a CAGR of 5.13%. Instruments segment is ... Read More
-
Global Brain Cancer Diagnostics Databank Market Report
... 2023 to 2031. Imaging Test segment is expected to be the highest contributor to this market, with $694.7 Million in 2022, and is anticipated to reach $1,223.4 Million by 2031, registering a CAGR of 6.54%. ... Read More
-
Global Hematologic Malignancies Databank Market Report
... 2029. Leukemia segment is expected to be the highest contributor to this market, with $13,172.5 Million in 2020, and is anticipated to reach $25,934.9 Million by 2029, registering a CAGR of 7.87%. Lymphoma segment is ... Read More
-
Global Acute Myeloid Leukemia Therapeutics Databank Market Report
... 5.19% from 2023 to 2031. Targeted Therapy and Immunotherapy segment is expected to be the highest contributor to this market, with $5,909.9 Million in 2022, and is anticipated to reach $8,938.5 Million by 2031, registering ... Read More
-
Global Castrate-resistant Prostate Cancer Databank Market Report
... 2023 to 2031. Hormonal Therapy segment is expected to be the highest contributor to this market, with $7,227.4 Million in 2022, and is anticipated to reach $12,564.7 Million by 2031, registering a CAGR of 6.39%. ... Read More
-
Global Cancer Registry Software Databank Market Report
... from 2023 to 2031. Integrated segment is expected to be the highest contributor to this market, with $35.1 Million in 2022, and is anticipated to reach $42.9 Million by 2031, registering a CAGR of 2.28%. Read More
Research Assistance
